Peer-Reviewed Journal Details
Mandatory Fields
Leamy D.;Kocijan J.;Domijan K.;Duffin J.;Roche R.;Commins S.;Collins ;Ward T.
2015
January
Journal of NeuroEngineering and Rehabilitation
An exploration of EEG features during recovery following stroke - Implications for BCI-mediated neurorehabilitation therapy
Published
22 ()
Optional Fields
BCI CSP EEG Stroke rehabilitation
11
1
Background: Brain-Computer Interfaces (BCI) can potentially be used to aid in the recovery of lost motor control in a limb following stroke. BCIs are typically used by subjects with no damage to the brain therefore relatively little is known about the technical requirements for the design of a rehabilitative BCI for stroke. Methods. 32-channel electroencephalogram (EEG) was recorded during a finger-tapping task from 10 healthy subjects for one session and 5 stroke patients for two sessions approximately 6 months apart. An off-line BCI design based on Filter Bank Common Spatial Patterns (FBCSP) was implemented to test and compare the efficacy and accuracy of training a rehabilitative BCI with both stroke-affected and healthy data. Results: Stroke-affected EEG datasets have lower 10-fold cross validation results than healthy EEG datasets. When training a BCI with healthy EEG, average classification accuracy of stroke-affected EEG is lower than the average for healthy EEG. Classification accuracy of the late session stroke EEG is improved by training the BCI on the corresponding early stroke EEG dataset. Conclusions: This exploratory study illustrates that stroke and the accompanying neuroplastic changes associated with the recovery process can cause significant inter-subject changes in the EEG features suitable for mapping as part of a neurofeedback therapy, even when individuals have scored largely similar with conventional behavioural measures. It appears such measures can mask this individual variability in cortical reorganization. Consequently we believe motor retraining BCI should initially be tailored to individual patients. © 2014 Leamy et al.; licensee BioMed Central Ltd.
1743-0003
10.1186/1743-0003-11-9
Grant Details